Patent directory · USPTO A61K / A61P
Patents matching “combination”
418 pharma patents match "combination" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.
Quick answer
This filtered view shows 418 pharmaceutical patents matching "combination" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.
Patent results
-
US 6444668
Combination regimens using progesterone receptor modulators
expired -
US 6423699
Combination therapies using benzimidazolones
expired -
US 6410603
Active topical skin protectants using combinations of reactive nanoparticles and polyoxometalates or metal salts
expired -
US 6333313
Clinical use of oxytocin alone or in combination to treat bone disorders
expired -
US 6329416
Combination regimens using 3,3-substituted indoline derivatives
expired -
US 6258845
DFMO and sulindac combination in cancer chemoprevention
expired -
US 6203787
Treating tumors using implants comprising combinations of allogeneic cells
expired -
US 6147060
Treatment of carcinomas using squalamine in combination with other anti-cancer agents
expired -
US 6040340
Implantation rates after in vitro fertilization, treatment of infertility and early pregnancy loss with a nitric oxide donor alone or in combination with progesterone, and a method for contraception with nitric oxide inhibitors
expired -
US 6028106
Treatment of urinary incontinence with nitric oxide synthase substrates and/or nitric oxide donors alone or in combination with estrogen or progesterone and/or other agents
expired